Array Biopharma
Qiagen Inks Master CDx Collaboration With Array BioPharma
One of the first projects between the firms will be to develop and commercialize a companion diagnostic for the MEK inhibitor binimetinib in NRAS-mutant melanoma.
Originally published June 2.
Originally published Oct. 29.